SYK

Stryker Corp.

Price

$345.81

return (12m)

p/e

36.85

p/bv

5.35

DIVIDEND YIELD

1.07%

SYK price

Stryker

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SYK

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals SYK

Valuation

P/E

36.85

Sector -2.34

Industry 11.10

P/BV

5.35

Sector 2.17

Industry 3.33

P/Revenue (PSR)

4.87

Sector 2.00

Industry 1.71

EV/EBITDA

103.42

Sector -23.69

Industry -398.52

EV/EBIT

134.51

Sector -36.60

Industry -80.73

P/EBITDA

19.01

Sector -0.10

Industry 8.30

P/EBIT

23.44

Sector -2.08

Industry 5.69

P/Total Assets

2.66

Sector 1.18

Industry 1.57

P/Net Current Assets

-12.33

Sector -10.91

Industry -3.38

P/Working Capital

17.51

Sector 0.09

Industry 10.51

EPS

8.71

Sector -0.93

Industry 1.10

BVPS

60.00

Sector 3.87

Industry 14.82

Efficiency

Gross Margin

63.83%

Sector 44.28%

Industry 29.23%

EBITDA Margin

21.56%

Sector -291.45%

Industry 4.29%

EBIT Margin

16.58%

Sector -195.44%

Industry 1.44%

Operating Margin

20.27%

Sector -25.72%

Industry 2.16%

Net Profit Margins

13.21%

Sector -30.19%

Industry 2.77%

Asset Turnover

0.13

Sector 0.12

Industry 0.27

Profitability

ROE

14.52%

Sector -34.71%

Industry 6.97%

ROA

7.21%

Sector -28.76%

Industry 2.97%

ROIC

8.53%

Sector -441.27%

Industry -5.31%

Dividends

Dividend yield

1.07%

Sector -

Industry 0.01%

Payout

39.43%

Sector -

Industry 0.54%

Debt

Current Ratio

2.11

Sector 1.87

Industry 1.51

Net Debt / EBITDA

8.67

Sector -2.18

Industry -1.68

Net Debt / EBIT

11.28

Sector -0.74

Industry -7.00

Net Debt / Equity

0.49

Sector -0.34

Industry 0.05

Gross Debt / Equity

0.62

Sector -0.64

Industry 0.35

Equity/Assets

0.50

Sector 0.43

Industry 0.46

Liabilities/Assets

0.50

Sector 0.46

Industry 0.52

Growth

5Y Revenue CAGR

8.11%

Sector -

Industry -

5Y Earnings CAGR

10.85%

Sector -

Industry -

FAIR VALUE OF Stryker ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$345.81

Fair Value

$108.44

Upside Return potential.

-68.64%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals SYK

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SYK Stryker Corp.	$345.81	-0.09%	1.07%	36.85	5.35	14.52%	13.21%
EW Edwards Lifesciences Corp.	$78.21	12.69%	0.00%	45.55	4.82	10.58%	17.34%
BSX Boston Scientific Corp.	$63.80	-31.89%	0.00%	18.45	2.54	13.78%	17.29%
ABT Abbott Laboratories	$101.06	-18.35%	0.00%	25.64	3.09	12.06%	13.91%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
ALGN Align Technology Inc.	$184.69	12.52%	0.00%	27.86	2.89	10.36%	10.50%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SYK Historical Dividends

current DY: 1.07%

5-year average DY: 1.01%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	03/31/2026	04/30/2026	0.88000000
Dividends	12/31/2025	01/30/2026	0.88000000
Dividends	09/30/2025	10/31/2025	0.84000000
Dividends	06/30/2025	07/31/2025	0.84000000
Dividends	03/31/2025	04/30/2025	0.84000000
Dividends	12/31/2024	01/31/2025	0.84000000
Dividends	09/30/2024	10/31/2024	0.80000000
Dividends	06/28/2024	07/31/2024	0.80000000
Dividends	03/29/2024	04/30/2024	0.80000000
Dividends	12/29/2023	01/31/2024	0.80000000
Dividends	09/29/2023	10/31/2023	0.75000000
Dividends	06/30/2023	07/31/2023	0.75000000
Dividends	03/31/2023	04/28/2023	0.75000000
Dividends	12/30/2022	01/31/2023	0.75000000
Dividends	09/30/2022	10/31/2022	0.69500000
Dividends	06/30/2022	07/29/2022	0.69500000
Dividends	03/31/2022	04/29/2022	0.69500000
Dividends	12/31/2021	01/31/2022	0.69500000
Dividends	09/30/2021	10/29/2021	0.63000000
Dividends	06/30/2021	07/30/2021	0.63000000
Dividends	03/31/2021	04/30/2021	0.63000000
Dividends	12/31/2020	01/29/2021	0.63000000
Dividends	09/30/2020	10/30/2020	0.57500000
Dividends	06/30/2020	07/31/2020	0.57500000
Dividends	03/31/2020	04/30/2020	0.57500000
Dividends	12/31/2019	01/31/2020	0.57500000
Dividends	09/30/2019	10/31/2019	0.52000000
Dividends	06/28/2019	07/31/2019	0.52000000
Dividends	03/29/2019	04/30/2019	0.52000000
Dividends	12/31/2018	01/31/2019	0.52000000
Dividends	09/28/2018	10/31/2018	0.47000000
Dividends	06/29/2018	07/31/2018	0.47000000
Dividends	03/29/2018	04/30/2018	0.47000000
Dividends	12/29/2017	01/31/2018	0.47000000
Dividends	09/29/2017	10/31/2017	0.42500000
Dividends	06/30/2017	07/31/2017	0.42500000
Dividends	03/31/2017	04/28/2017	0.42500000
Dividends	12/30/2016	01/31/2017	0.42500000
Dividends	09/30/2016	10/31/2016	0.38000000
Dividends	06/30/2016	07/29/2016	0.38000000
Dividends	03/31/2016	04/29/2016	0.38000000
Dividends	12/31/2015	01/29/2016	0.38000000
Dividends	09/30/2015	10/30/2015	0.34500000
Dividends	06/30/2015	07/31/2015	0.34500000
Dividends	03/31/2015	04/30/2015	0.34500000
Dividends	12/31/2014	01/30/2015	0.34500000
Dividends	09/30/2014	10/31/2014	0.30500000
Dividends	06/30/2014	07/31/2014	0.30500000
Dividends	03/31/2014	04/30/2014	0.30500000
Dividends	12/31/2013	01/31/2014	0.30500000
Dividends	09/30/2013	10/31/2013	0.26500000
Dividends	06/28/2013	07/31/2013	0.26500000
Dividends	03/29/2013	04/30/2013	0.26500000
Dividends	12/31/2012	01/31/2013	0.26500000
Dividends	09/28/2012	10/31/2012	0.21250000
Dividends	06/29/2012	07/31/2012	0.21250000
Dividends	03/30/2012	04/30/2012	0.21250000
Dividends	12/29/2011	01/31/2012	0.21250000
Dividends	09/30/2011	10/31/2011	0.18000000
Dividends	06/30/2011	07/29/2011	0.18000000
Dividends	03/31/2011	04/29/2011	0.18000000
Dividends	12/31/2010	01/31/2011	0.18000000
Dividends	09/30/2010	10/29/2010	0.15000000
Dividends	06/30/2010	07/30/2010	0.15000000
Dividends	03/30/2010	04/30/2010	0.15000000
Dividends	12/30/2009	01/29/2010	0.15000000
Dividends	11/18/2009	12/16/2009	0.10000000
Dividends	12/31/2008	01/30/2009	0.39920000
Dividends	12/31/2007	01/31/2008	0.32930000
Dividends	12/29/2006	01/31/2007	0.21960000
Dividends	12/30/2005	01/31/2006	0.10980000
Dividends	12/31/2004	01/31/2005	0.08980000
Dividends	12/31/2003	01/30/2004	0.06990000
Dividends	12/31/2002	01/31/2003	0.05990000
Dividends	12/31/2001	01/31/2002	0.04990000
Dividends	12/29/2000	01/31/2001	0.03990000
Dividends	12/31/1999	01/31/2000	0.03240000
Dividends	12/31/1998	01/29/1999	0.007500
Dividends	12/31/1997	01/30/1998	0.02740000
Dividends	12/31/1996	01/31/1997	0.006250
Dividends	12/29/1995	01/31/1996	0.01120000
Dividends	12/30/1994	01/31/1995	0.01000000
Dividends	12/31/1993	01/31/1994	0.008700
Dividends	12/31/1992	01/29/1993	0.007500
Dividends	12/31/1991	01/31/1992	0.006200

ABOUT Stryker

Stryker Corp.

Average Investor10 user rating

4.0 (0 people)

States of America

80 years

Founded: 1946

1988

Time since IPO - 38 years

43.000

Employees

Stryker Corp. (States of America) is listed on the NYSE and has a market capitalization of $122.99 billion, with shareholders equity totaling $22.98 billion.

The company employs approximately 43.000 people and operates in the Saúde sector, within the Materiais e Equipamentos Médicos industry.

Over the past 12 months, Stryker Corp. reported $25.27 billion in revenue, generating net income of $3.34 billion.

Key financial metrics include a P/E ratio of 36.85, a price-to-book (P/B) ratio of 5.35, and a trailing twelve-month dividend yield of 1.07%.

The company trades under the ticker SYK.

Market cap

$122.99 billion

Net worth

$22.98 billion

$22,979,000,000.00

Assets

$46.29 billion

$46,291,000,000.00

Total Shares Outstanding

383.00 million

383,000,000

Average Daily Trading Volume

$2.82 million

$2,820,352.00

Sector

Saúde

Industry

Materiais e Equipamentos Médicos

SYK

revenue by Business Segment Stryker

SYK revenue and profits

Financial Results SYK

DRAG THE FRAME TO SEE MORE DATA

SYK cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

SNY - Sanofi

$47.64 --3,72% (12M)

P/E

7.21

4.00%

ROE

17.79%

P/BV

1.28

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$498.78 47,18% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56